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A B S T R A C T Erythroid burst forming units (BFU-E)
are proliferative cells present in peripheral blood and
bone marrow which may be precursors of the erythroid
colony forming cell found in the bone marrow. To ex-
amine the possible role of monocyte-macrophages in
the modulation of erythropoiesis, the effect of mono-
cytes on peripheral blood BFU-E proliferation in re-
sponse to erythropoietin was investigated in the plasma
clot culture system. Peripheral blood mononuclear cells
from normal human donors were separated into four
fractions. Fraction-I cells were obtained from the inter-
face of Ficoll-Hypaque gradients (20-30% monocytes;
60-80% lymphocytes); fraction-II cells were fraction-I
cells that were nonadherent to plastic (2-10% mono-
cytes; 90-98% lymphocytes); fraction-III cells were
obtained by incubation of fraction-II cells with carbonyl
iron followed by Ficoll-Hypaque centrifugation (>99%
lymphocytes); and fraction-IV cells represented the ad-
herent population of fraction-II cells released from the
plastic by lidocaine (>95% monocytes). When cells
from these fractions were cultured in the presence of
erythropoietin, the number of BFU-E-derived colonies
was inversely proportional to the number of monocytes
present (r = -0.96, P < 0.001). The suppressive effect
of monocytes on BFU-E proliferation was confirmed
by admixing autologous purified monocytes (fraction-
IV cells) with fraction-III cells. Monocyte concentra-
tions of -20% completely suppressed BFU-E activity.
Reduction in the number of plated BFU-E by mono-
cyte dilution could not account for these findings: a
15% reduction in the number of fraction-III cells plated
resulted in only a 15% reduction in colony formation.
These results indicate that monocyte-macrophages may
play a significant role in the regulation oferythropoiesis
and be involved in the pathogenesis of the hypopro-
liferative anemias associated with infection and certain
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neoplasia in which increased monocyte activity and
monopoiesis also occur.
INTRODUCTION
It is generally accepted that erythropoietin (Ep)l reg-
ulates mammalian erythropoiesis (1, 2). Several lines
of evidence suggest that cell-cell interactions also play
an important role in the production of erythrocytes.
Lymphocyte effects on in vivo erythropoiesis have been
observed in several animal systems. Goodman and
Shinpock (3) showed that proliferation of parent marrow
in irradiated hybrid mice was enhanced by concomitant
injection of parental thymus-derived cells. The degree
of this enhancement was related to the number of thy-
mus-derived cells injected. A recent study (4) dem-
onstrates that the ability of the genetically normal
(+/+) bone marrow or spleen cells to correct the macro-
cytic anemia of W/Wv mice may be thymus-derived-
cell dependent: treatment of these donor cells with
complement and anti-sera to the thymus-derived-cell
antigen Thy 1.2 abolishes their effect. Petrov et al.
(5) have shown that the transfer of lymphocytes to-
gether with allogeneic bone marrow cells into lethally
irradiated recipient mice resulted in the inactivation of
spleen colony forming units; this effect was not linked
to the H-2 histocompatibility system (6). The avail-
ability of culture techniques for the study of prolifera-
tion and differentiation of erythropoietic precursors in
vitro has provided additional support for the existence
of regulatory processes involving cell-cell interaction
in erythropoiesis. Thus, suppression of normal human
bone marrow erythroid colony forming units (CFU-E)
by peripheral blood lymphocytes from some patients
with Diamond-Blackfan syndrome (7) and aplastic
anemia has been described (8). Steinberg et al. have
'Abbreviations used in this paper: BFU-E, erythroid burst
forming units; CFU-E, erythroid colony forming units; EC,
erythroid colonies; Ep, erythropoietin; F, fraction.
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also described suppression of erythroid burst forming
units (BFU-E) by circulating thymus-derived cells from
patients with Diamond-Blackfan syndrome (9).
In a preliminary study of human peripheral blood
erythroid precursors, we used the plasma clot culture
system (10) and previously described cell separation
techniques (11). As others have shown, we found a
highly variable number ofBFU-E/105 mononuclear cells
from normal donors. We undertook a study of this vari-
ability and found that normal BFU-E proliferation was
modulated by monocytes. When procedures conducive
to the preservation of circulating monocytes were em-
ployed in the preparation of blood mononuclear cells,
the proliferation and (or) differentiation of BFU-E was
found to be inversely related to the number of mono-
cytes present. Thus, BFU-E proliferation was com-
pletely inhibited in the presence of >20% monocytes.
Removal of monocytes resulted in marked enhance-
ment ofBFU-E proliferation. Addition of purified mono-
cytes to monocyte-depleted mononuclear cells in-
hibited BFU-E proliferation.
METHODS
After informed consent was obtained, blood was drawn from
normal human donors, heparinized, and separated by a mod-
ification of the isopycnic gradient technique previously de-
scribed (11). Briefly, blood was diluted 1:1 with Seligman's
balanced salt solution (Ficoll, Pharmacia Fine Chemicals,
Piscataway, N. J.; Hypaque, Winthrop Laboratories, Sterling
Drug Co., New York), (1.077 sp gr), and centrifuged
at 400 g for 25 min at 15°C. In specific experiments to be
described, isopycnic gradient centrifugations were performed
by varying the time and temperature and by using Ficoll-
Paque (Pharmacia Fine Chemicals) (1.077 sp gr) instead
of Ficoll-Hypaque. Interface cells, designated as frac-
tion (F)-I, were utilized in cultures or were further separated
into three cell fractions (Fig. 1); F-I cells were adjusted to
1.5 x 106 monocytes/ml of RPMI containing 20% autologous
sera. The percentage of monocytes in each fraction was de-
termined by latex phagocytosis, Sudan black positivity and
morphology of Giemsa-stained cytocentrifuge preparation.
The values obtained by these techniques correlated closely(±+3%). 3-ml aliquots were placed into 60-mm culture dishes
which were incubated 1.0 h at 37°C. Nonadherent cells, des-
ignated as F-II cells, were removed by washing culture dishes
six times with Hanks' balanced salt solution, then centrifuged,
and suspended in autologous plasma. Carbonyl iron (25 mg/
ml) was added, the mixture was rotated for 30 min at 37°C,
and then layered over Ficoll-Hypaque. After centrifugation
at 400 g for 30 min at room temperature, the resultant in-
terface cells were obtained and designated as F-III. F-I cells
that had adhered to culture dishes were isolated as follows.
After nonadherent cells (F-II) were removed by washing, 3.0
ml of Seligman's balanced salt solution containing 30 mM
lidocaine and 10% autologous sera were added to each cul-
ture dish and incubated for 15 min at room temperature. Ad-
herent cells were detached by this treatment or were removed
by gently streaming Seligman's balanced salt solution onto
residual attached cells. These suspended (previously ad-
herent) cells were then washed three times by centrifugation
to remove lidocaine and were designated as F-IV.
The plasma clot system used in these studies to culture
erythroid cells has been previously described (10, 12). Briefly,
Heporinized Blood
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FIGURE 1 Schematic representation of cell separation. See
text for details of the procedure.
cells were suspended to 0.5-4 x 106/1.1 ml of media com-
posed of 0.3 ml fetal calf serum, 0.1 ml bovine serum al-
bumin (10% in phosphate-buffered saline), 0.1 ml L-asparigine
(2 mg/ml NCTC-109, Hyland Laboratories, Los Angeles,
Calif.), 0.1 ml a-thioglycerol (10 mM, NCTC-109), 0.1 ml
citrated bovine plasma, and contained 0.5, 1, 2, 4, or 6 U of
Ep. For each experimental point eight 0.1-ml/well cultures
were established and incubated at 37°C in humidified air with
5% CO2 for 14 days. Clots were then removed, placed on
glass slides,fixed with glutaraldehyde, and stained with ben-
zidine.
Ep was assayed as follows. Female CF-I mice were made
polycythemic by exposure to 0.4 atmosphere barometric pres-
sure 19 h/day for a total of 219 h. Animals were then injected
i.p. with different volumes of media (adjusted to 1 ml with
saline) to be assayed for Ep or with standard quantities of
Ep on days 5 and 6 posthypoxia. Radioiron (0.5 S.Ci/mouse)
was given i.v. on day 7 and the percent erythrocyte-_9Fe uptake
was determined on day 9. 6-10 mice were used to test each
sample and standard; the units of Ep in each sample were
determined from a standard curve as previously described (13).
Materials for these experiments were obtained as follows:
Ficoll 400, Dextran 200, and Ficoll-Paque, Pharmacia Fine
Chemicals; Hypaque (50%), Winthrop Laboratories, Sterling
Drug Co.; 60-mm tissue culture dishes, Falcon Plastics, Div.
of BioQuest, Oxnard, Calif.; Hanks' balanced salt solution and
fetal calf serum, Gibco, Grand Island, N. Y.; RPMI 1640, Asso-
ciated Biomedic Systems, Inc., Buffalo, N. Y.; L-asparigine
and bovine serum albumin, Calbiochem, San Diego, Calif.;
citrated bovine plasma, Colorado Serum Co., Denver, Colo.;
NCTC-109, Microbiological Associates, Walkersville, Md.;
thrombin (bovine), Parke, Davis & Co., Detroit, Mich.; a-
thioglycerol, Aldrich Chemical Co., Milwaukee, Wis.; lido-
caine (40 mg/ml), Astra Pharmaceutical Products, Inc., Wor-
cester, Mass.; carbonyl iron powder, GAF Corp., New York;
erythropoietin was supplied by the National Institutes of
Health, Blood Resources Divison.
RESULTS
In a preliminary study of human peripheral blood
BFU-E, we used the cell separation technique origi-
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nally described by Boyum (11). Resultant cells from
normal donors were cultured in the plasma clot sys-
tem and, as previously reported (10), variable numbers
of BFU-E/105 cells resulted (Table I). We suspected
that this variability in BFU-E proliferation might be a
result ofmonocyte contamination ofthe cultured mono-
nuclear cells. To examine this possibility, we used a
separation technique to preserve monocyte number and
viability in the initial separation step. Subsequent
steps specifically depleted this mononuclear prepara-
tion of monocytes (Fig. 1). This cell separation pro-
cedure resulted in a large number of monocytes in
F-I and in progressively fewer monocytes in F-II, and
-III (Table II). F-IV (adherent cells) consisted of 95%
monocytes which we have previously shown to be
functionally equivalent to the unseparated monocytes
in F-I (14). Table II also demonstrates the formation
of BFU-E-derived colonies by these fractions in the
presence of Ep.
The numbers of BFU-E were determined under
x 10 magnification and areas of erythroid activity form-
ing a distinct grouping of benzidine-positive subunits
were considered as a single BFU-E colony. Although
not all such subunits exhibited benzidine positivity
in every colony, generally 60-80% were stained with
benzidine. In general, no difficulties in identifying such
distinct areas of erythroid "burst" activity were ex-
perienced with concentrations of mononuclear cells
up to 2 x 106 cells/1.1 ml ofthe culture. The determina-
TABLE I
Preliminary Study of Peripheral Blood BFU-E
Normal donors* No. of BFU-E/105 cellst
1 6
2 7
3 11
4 9
5 7
6 12
7 10
8 4
9 11
10 8
11 18
12 9
13 10
14 6
15 7
* Blood was diluted with Hanks' balanced salt solution,
layered over Ficoll-Hypaque (specific gravity, 1.077), and
centrifuged in glass tubes at 400 g for 30 min at 20°C. Interface
cells were washed in Hanks' balanced salt solution and then
generally allowed to stand in glass tubes on ice 1 h. Resultant
cells were cultured in the plasma clot system with 4 U Ep/2
x 106 cells at 2 x 105 cells/0.1 ml culture.
t Mean+SE = 9+0.8.
TABLE II
Relationship between Cell Fractions, Percent Monocytes,
and BFU-E-Derived Colonies in Plasma Clot Cultures
No. of BFU-E/10' cells*
Cell
fraction Monocytes No Ep +4 IU EpI
F-I 30±3 0 1.1±0.5
F-Il 6+1 0 10.9±2.5
F-III 0.6±0.2 0 20.7±2.9
F-IV 95 0 0
* Each value represents the mean± 1 SE of nine separate
studies.
t Ep used in these studies was collected and concentrated
by the Department of Physiology, University of Northeast,
Corrientes, Argentina, and further processed and assayed by
the Hematology Research Laboratories, Children's Hospital
of Los Angeles, Los Angeles, Calif., under grant HE-10880
from the National Heart, Lung, and Blood Institute of the
National Institutes of Health.
tions of BFU-E colonies, however, were more difficult
with starting cell concentrations of 3 x 106 cells/1.1 ml
of culture medium and became almost impossible when
4 x 106 cells were used. In the latter case, the growth
was confluent with no clear separation of areas of ery-
throid activity. When 2 x 105 F-III cells/well were cul-
tured with various amounts of Ep, there was a linear
increase in the number of erythroid colonies (EC)
formed between 0.5 and 2.0 U of Ep/ml; no significant
increase in EC occurred with 2.5-6 U of Ep/ml (Fig. 2).
The number of EC formed were directly proportional
to the number of F-III cells (0.5-3 x 106 cells) plated
in the presence of a constant concentration ofEp (Fig. 3).
When cells in F-I, -II, and -III were cultured sep-
arately, the number of EC formed at 14 days was in-
versely related to the number of monocytes present in
each fraction (Table II).
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FIGURE 2 Effect of different doses of Ep on BFU-E-derived
erythroid colony formation by monocyte-depleted (F-III) frac-
tion of peripheral blood mononuclear cells in plasma clot cul-
tures. Each point represents the mean+SE of six separate
experiments.
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FIGURE 3 Effect of increasing concentrations of cells from
monocyte-depleted (F-III) fraction of peripheral blood mono-
nuclear cells on BFU-E-derived erythroid colony formation
in the presence of 4 IU Ep in plasma clot cultures. Each
pointrepresents the mean+SE ofseven separate experiments.
The correlation coefficient between the percentage
of monocytes (0-15%) and the number of EC formed
from 105 F-I, -II, or -III cells was 0.96, P < 0.001. Es-
sentially no EC were formed when >20% monocytes
were present (Fig. 4). To further examine the relation-
ship between monocyte number and BFU-E prolifera-
tion, purified autologous monocytes (F-IV) were ad-
mixed with F-III cells to yield a constant final con-
centration of 2 x 106 cells/1.1 ml containing 0, 5, 15,
and 30% monocytes (Table III). Under these conditions
the number of EC formed was inversely proportional
to the percentage of monocytes present. Because a con-
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FIGURE 4 The relationship between BFU-E-derived ery-
throid colony formation and the percentage ofmonocytes pres-
ent in peripheral blood mononuclear cells. Each dot repre-
sents a single experiment. The regression line was de-
termined by the least square analysis of data obtained from
cultures containing 0-15% monocytes.
TABLE III
Effect ofPurified Monocytes (F-IV Cells) ont Erythroid Colony
Formation by Monocyte-Depleted Fraction (F-Ill Cells)
of Peripheral Blood Mononuclear Cells in
Plasma Clot Cultures
No. ofBFU-E/105 cells*
No. of F-III cells No. of F-IV cells No Ep +4 IU Ep
1.4 x 106 0 0 17.8±+1.0
1.4 x 106 600,000 0 0
1.7 x 106 0 0 21.4±+1.3
1.7 x 106 300,000 0 2.1+0.5
1.9 X 106 0 0 22.9±+1.5
1.9 X 106 100,000 0 11.3±+1.0
* Each value represents the mean±+l SE of eight separate
studies. Values are based on numbers of F-III cells plated.
Total number of cells (F-III and F-IV) was 2.0 x 106
cells/1.1 ml.
stant number of cells per well were used in the pre-
vious experiments, the possibility existed that the re-
duction in EC was a result of dilution of BFU-E by
monocytes. To examine this question, various numbers
of autologous F-IV cells were co-cultured with a con-
stant number of F-III cells (Table IV). The number
of EC were reduced as increasing numbers of F-IV
cells (95% monocytes) were added. Thus the observed
monocyte suppression ofEC formation was not directly
related to BFU-E dilution alone.
Because Ep is essential for normal BFU-E prolifera-
tion (no colonies were formed in the absence of Ep),
monocyte absorption or utilization of Ep could sup-
press EC formation. However, the experiments just
TABLE IV
Effect ofPurified Monocytes (F-IV Cells) on Erythroid Colony
Formation by Monocyte-Depleted Fraction (F-III
Colls) of Peripheral Blood Mononuclear
Cells in Plasma Clot Cultures
No. ofBFU-E/105 cells*
No. of F-III cells No. of F-IV cells No Ep + 4 IU Ep
2 x 106 0 0 24.6+2.1
2 x 106 40,000 0 18.3±+1.8
2 x 106 80,000 0 12.9+2.3
2 x 106 120,000 0 9.7± 1.2
2 x 106 200,000 0 5.1±0.8
2 x 106 300,000 0 2.6+0.7
2 x 106 480,000 0 0
* Each value represents the mean+ 1 SE of six separate
studies. Values are based on numbers of F-III cells plated.
Total number of cells (F-III and F-IV) ranged from 2.04 to
2.48 x 106 cells/1.1 ml depending upon the number of
monocytes added to cultures.
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described were performed with an excess of Ep (4 U/
ml), so monocyte utilization ofEp is unlikely. To further
examine this possibility, 1-4 x 106 F-I cells were
preincubated with culture media containing 1-4 U
of Ep/ml for 0.5 or 36 h at 37°C. Media were then freed
of cells by centrifugation and tested for Ep depletion.
Preincubated media exhibited no reduction in Ep activ-
ity when measured in the exhypoxic polycythemic
mouse (Table V). Therefore, it is most unlikely that
monocytes suppress EC formation by decreasing the
availability of Ep to BFU-E.
To determine if suppression of BFU-E was a non-
specific effect of the co-culture of heterologous cells,
F-III cells were cultured alone, with 30% monocytes
(F-IV), or 30% granulocytes; resultant BFU-E/105 F-
III cells were 29±14, 1±0.5, and 28+10, respectively
(n = 3).
The following experiment was performed to deter-
mine ifmonocyte suppression ofBFU-E required direct
cell-cell contact. Monocyte monolayers were prepared
by adding various numbers of F-IV cells to microwells
in 0.1 ml of RPMI containing 20% autologous serum
and permitted to adhere to the plastic for 1 h. F-Ill
cells (2 x 105) alone or with monocytes were plated in
separate microwells in complete plasma medium and
allowed to clot. The supernate was then removed from
monocyte monolayers and the plasma clots containing
TABLE V
Effect of Peripheral Blood Mononuclear (PBM)
Cells on Ep In Vitro*
IRP equivalent units of Ep/culture§
No. of PBMI In medium alone Medium + PBM
1 X 106 1 (13.6+1.3)1 1 (14.8±2.1)
1 x 106 2 (19.4±1.9) 2 (17.9±2.3)
1 x 106 4 (16.2± 1.7) 4 (16.5±0.8)
2 x 106 1 (8.2±0.9) 1 (9.3±1.0)
2 x 106 2(12.7±1.1) 2 (15.8±2.9)
2 x 106 4 (15.3±2.0) 4 (14.7± 1.6)
4 x 106 1 (11.2± 1.2) 1 (13.6± 1.4)
4 x 106 2 (9.9±0.5) 2 (11.3±1.7)
4 x 106 4 (19.8+ 1.8) 4 (19.0±2.0)
* Erythropoietin and different numbers of PBM were incu-
bated together for 0.5 h (1 and 2 x 106 cells) or 36 h (4 x 106
cells) at 37°C in a humidified atmosphere of 5% CO2 in air;
controls consisted of incubating the hormone in medium
without PBM.
t PBM contained about 30% monocytes.
§ Media were assayed in exhypoxic polycythemic mice and
the percent erythrocytes-59Fe uptakes converted to equivalent
units of Ep by reference to dose-response curve established
for the International Reference Preparation (IRP) of Ep.
¶ The values in parentheses indicate the percent erythrocytes-
59Fe uptake in assay mice induced by similar volumes of
media from each category.
F-III cells and Ep were transferred by "flipping" onto
monocyte monolayers or onto control wells (which had
contained RPMI with 20% autologous serum alone).
Thus, BFU-E proliferation was compared in clots con-
taining (a) F-III cells, (b) monocytes plus F-III cells,
and (c) in clots containing F-III cells that were placed
over preformed monocyte monolayers. Monocytes sup-
pressed BFU-E formation whether they were placed
in or under clots containing F-III cells (Table VI).
Several investigators have reported that BFU-E pres-
ent in interface fractions of isopycnic gradients pro-
liferated without monocyte depletion of this fraction
(15). To determine if standard centrifugation time (40
min) and temperature (room temperature) might par-
tially deplete interface cells of monocytes and thus
explain these apparently incongruous observations, the
following experiment was performed. Blood was di-
luted as previously described, layered over Ficoll-
Hypaque or commercially prepared Ficoll-Paque, and
then centrifuged for 25 min at 15°C or for 40 min at
room temperature (25°C). Increasing the time and tem-
perature reduced the number of monocytes present
two- to fourfold (Table VII). The results in Table VII
once again demonstrate a relationship between the
number of BFU-E-derived colonies and the percent
monocytes present in the cell preparation.
DISCUSSION
These data demonstrate that human monocytes sup-
press EC formation from peripheral blood BFU-E. The
number of EC formed from peripheral blood mono-
nuclear cells was inversely related to the number of
monocytes present. Furthermore, addition of purified
monocytes to monocyte-depleted mononuclear prep-
arations inhibited EC formation.
Monocytes did not inhibit EC formation by utiliza-
tion or absorption of EP because (a) preincubation of
TABLE VI
Effect of Monocytes on Erythroid Colony Formation:
Influence of Monocyte Proximity to F-Ill Cells
F-III + monocytest F-III cells + monocyte5
Monocytes (premixed) (monolayer)
0 23+10 23+10
10 4+2 15+6
20 0.5+0.5 12+7
30 0.5+0.5 3+2
* 2 x 106 F-Ill cells and 4 IU Ep were used.
t Monocytes and F-III cells were admixed and cultured for
14 days. Numbers represent mean + 1 SE ofthree experiments.
§ F-III cells were added to wells in complete media and
allowed to form clots before being transferred to other
microwells containing monocyte monolayers.
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TABLE VII
Effect of Temperature, Time of Centrifugation, and Type of
Ficoll-Hypaque on Monocyte Content and BFU-E
Proliferation in Separated Peripheral
Blood Mononuclear Cells*
Monocytes
Monocytes (Sudan black No. of BFU-
Separation conditions (morphology)t positivity) I E/105 cellst
Ficoll-Hypaque§
25 min, 15°C 18+2 22+1 2±0.4
40 min, 25°C 4±3 7±2 13±3
Ficoll-Paquel
25 min, 15°C 16±3 18±1 2±0.5
40 min, 25°C 6±1 9±1 8±2
* See text for explanation.
t Each value represents the mean 1 SE of three separate
studies.
§ Prepared in our laboratory with Hypaque purchased from
Winthrop Laboratories, Sterling Drug Co., Inc.
1 Ficoll-Paque was purchased from Pharmacia Fine Chemicals.
media containing Ep with F-I cells (30% monocytes)
did not reduce the quantity of Ep present as measured
by the exhypoxic polycythemic mouse, and (b) high
concentrations of Ep did not reverse monocyte sup-
pression of EC formation. It is unlikely that monocyte
suppression ofEC formation was a result of media de-
pletion because (a) only 10% monocytes significantly
suppressed EC formation, and (b) increasing the num-
ber of F-III cells cultured resulted in a linear increase
in the number of BFU-E and (c) granulocytes did not
inhibit BFU-E proliferation. The suppression of BFU-E
by added purified autologous monocytes was not a
result of the lidocaine employed in the recovery of
monocytes because the addition of lidocaine-treated,
bone marrow- or thymus-derived lymphocytes did not
inhibit BFU-E proliferation. Moreover, the degree of
observed BFU-E suppression was not related to
whether endogenous or purified autologous monocytes
were present in culture. In addition, functions of puri-
fied monocytes in F-IV and unfractionated monocytes
in F-I were equivalent (14).
Several possibilities exist as to the mechanism by
which monocytes affect erythropoiesis. It is possible
that monocytes might dilute BFU-E and thus reduce
the number plated. However, admixture of 4.8 x 105
monocytes and 2 x 106 F-III cells resulted in the maxi-
mum BFU-E dilution of 30% and complete inhibition
of EC formation (Table III). In contrast, a simple 30%
reduction in the number of plated F-III cells resulted
in only a 25-30% decrease in EC formation (Fig. 3).
In addition, the observed suppression was also sig-
nificant when the number of EC was expressed per
105 F-III cells plated. Moreover, when the number
of F-III cells plated was held constant in the presence
of purified monocytes, suppression ofEC formation oc-
curred (Table IV). Monocytes may exert their effect by
secreting substances capable of suppressing BFU-E.
In this regard murine macrophages have been shown
to secrete nontoxic chalones, cytotoxins, and prosta-
glandins that inhibit proliferation of a variety of non-
erythroid cells (16, 17). However, when media con-
ditioned by monocytes for 4-12 days were added to F-Ill
cells, BFU-E proliferation and (or) differentiation was
enhanced. This is in accord with recent observations
that leukocyte-conditioned media stimulates CFU-E
proliferation (18). However, these findings do not rule
out the possibility that a short-lived secretory product
with a local effect may mediate monocyte suppres-
sion of BFU-E proliferation. Finally, monocytes may
mediate their effects by direct cell-cell contact. How-
ever, data presented in Table VI suggest that monocyte
suppression of BFU-E may not involve cell-cell contact.
Three laboratories have previously reported BFU-E
proliferation when blood mononuclear cells obtained
by Ficoll-Hypaque gradients were cultured in the
plasma-clot system (10, 15, 19). These workers did not
note the suppressive effects of monocytes on BFU-E
that we have described here, and the number of viable
monocytes in their cultured preparations were not re-
ported. However, in the studies described here, ef-
forts were made to preserve as many viable monocytes
as possible in F-I. It should also be noted that a sig-
nificant reduction in monocyte number occurs if
blood is not used within 1 h of collection, when
mononuclear cells are washed or allowed to stand in
media containing divalent cations (monocyte-platelet
clumping occurs), and when Ficoll-Hypaque gradients
are centrifuged for longer than 25 min (Table VII).
In this regard, Papayannapoulou et al. (15) employed
mononuclear cells which had been at least partially
depleted of monocytes by adherence to plastic dishes
for 2 h. Clarke and Housman (10) obtained 9.8-20
BFU-E/105 nucleated cells (mean, 15.6), or 110-200/ml
blood. Similarly, Nathan et al. obtained 7-23 BFU-E/
105 cells (mean, 15.2) (19). It is of interest that (a)
this range of BFU-E resulted in our studies when cell
preparations were contaminated with 6-12% monocytes
(Fig-. 4) and that (b) this cell monocyte distribution
in Ficoll-Hypaque interface preparations is commonly
reported when no special efforts are made to preserve
monocyte number and is the same cell distribution
we found in our preliminary studies. In contrast, when
F-Ill cells containing --2% monocytes were cultured in
the same system, 28-32 BFU-E/105 cells (mean, 29.5,
Fig. 4), or 300-360/ml blood were observed. It is also
important to note that when cultured cells from normal
donors contained .2% monocytes (Fig. 4), minimal
variation in the number of BFU-E/ml blood or per 105
nucleated cells occurred. Therefore, it is possible that
the lower numbers and variability of BFU-E detected
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in other laboratories may be related to the presence
of variable numbers of monocytes in cultures.
Several in vivo and in vitro observations have sug-
gested that monocyte-macrophages may be involved in
the regulation of hematopoiesis. Trentin (20), for ex-
ample, described an erythroid hematopoietic inductive
microenvironment that plays an important role in direct-
ing the differentiation of the multipotential stem cell
or its progeny toward the erythroid line. A defect in
the hematopoietic inductive microenvironment is con-
sidered to be responsible for the genetically determined
anemia seen in Steel mice (21). Cells responsible for
the hematopoietic inductive microenvironment are
thought to be a type ofreticulo-endothelial cell because
they exhibit resistance to ionizing irradiation. The
phenomenon of"hybrid resistance" or "CFU-E repres-
sion" described by Cudkowicz and Stimpfling (22) and
McCulloch and Till (23) occurs in heavily irradiated
animals, is not enhanced by immunization and is un-
likely to involve B lymphocytes. Lotzova and Cud-
kowicz have implicated the macrophages in hybrid re-
sistance, because treatment of the host with silica, a
macrophage toxin, abrogated this phenomenon (24).
A recent report by Aye suggests that monocyte-macro-
phages enhance the proliferation of human bone mar-
row CFU-E and BFU-E, because removal of adherent
cell populations resulted in decreased bone marrow
CFU-E and BFU-E activity (18).
These findings are not necessarily discordant with
our observations. Bone marrow contains <1% mono-
cyte-macrophages, a concentration that did not inhibit
BFU-E proliferation in these studies (25). We could
not demonstrate monocyte enhancement of peripheral
blood BFU-E proliferation at low monocyte concentra-
tions (<1%) or when F-Ill was cultured at suboptimal
plating efficiency (<0.5 x 105 cells/culture) with 1-5%
monocytes. Nevertheless, this low concentration of
monocyte-macrophages may be necessary for optimal
bone marrow CFU-E and BFU-E proliferation. Also,
if an intermediate suppressor cell is necessary for me-
diation of the monocyte effect, such a suppressor cell
could be present in peripheral blood and absent in
bone marrow. Finally, bone marrow and peripheral
blood BFU-E may differ in their proliferative character-
istics and susceptibility to inhibition by monocytes.
A number ofclinical and laboratory observations sug-
gest that monocyte suppression ofEC formation in vitro
may have in vivo significance. Infection and treatment
of mice or rats with agents that enhance monopoiesis
and activate macrophages, suppress erythropoiesis and
enhance myelopoiesis (26, 27). Thus, increased bone
marrow content and activity of monocytes and macro-
phages could enhance myelopoiesis by increasing, in
situ, the concentration of colony stimulating factor. Con-
comitantly, BFU-E proliferation and eventually erythro-
cyte production may be reduced. In this regard, the
transient or persistent anemias associated with infec-
tions and neoplasms in man may be related to the en-
hanced proliferation and activity of monocytes in these
states (28-31).
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